Orchasp Ltd (ORCHASP)
Asset PlayScore breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1.46 |
| Market Cap | ₹50.58 Cr |
| P/E Ratio | 48.67 |
| ROCE | -8.26% |
| ROE | 3.51% |
| Dividend Yield | 0% |
| Profit Growth | -50% |
| Debt/Equity | 0.06 |
| Sales Growth | -64.9% |
| Promoter Holding | 11.62% |
| 52-Week Range | ₹1.13 — ₹4.16 |
| Sector | IT - Software |
| Book Value | ₹3.27 |
Strengths
- Price-to-book of 0.62 offers a 38% discount to stated book value of ₹3.30.
- Debt/equity is low at 0.14, reducing near-term solvency risk.
- Latest quarter net profit is ₹0 Cr, avoiding a reported loss despite weak sales.
- Market cap of ₹94 Cr gives small size that could attract strategic interest if operations stabilise.
Concerns
- Sales growth of -27.62% and profit growth of -62% show sharp business deterioration.
- ROCE is negative at -8.26%, indicating value destruction rather than productive capital use.
- Piotroski F-score of 2/9 points to poor overall financial health.
- Promoter holding of 11.62% is low, raising corporate-governance and alignment concerns.
AI Analysis
Orchasp appears on my screen as a classic Graham-style asset play: market price ₹2.06, book value ₹3.30, so it trades at only 0.62 times book. Market cap is ₹94 crore. But cheapness alone never excited me—it must be supported by a healthy business. Here, the fundamentals tell a different story. Sales are down 27.62%, profits have fallen 62%, and the latest quarter shows sales of just ₹4 crore and net profit of zero. Return on capital employed is negative at -8.26%, meaning the business is destroying value, not creating it. Return on equity is a weak 3.51%. The Piotroski F-score of 2 out of 9 reinforces my concern about financial deterioration. I also notice promoter holding is only 11.62%. In Indian software companies, that is low; I want owners to be heavily invested alongside me. The zero dividend yield is acceptable in a growth business, but there is no growth here—there is shrinkage. At a P/E of 23.62, the market is still paying a meaningful multiple for earnings that are collapsing. The one comforting point is the low debt-to-equity of 0.14, so the company is not at immediate financial risk. That gives time for a possible turnaround, but time is not a strategy. I can't call this a wonderful business. There is no apparent moat, no pricing power, no consistent profitability. If the book value is real and the company can stabilise operations, there may be an asset-backed entry. But if losses continue, book value will erode and the discount may widen. Paying ₹2.06 for ₹3.30 of book is only sensible if that book won't dissolve. I'd need evidence of stabilisation—positive operating momentum, improving margins, or promoter buying—before I commit. For now, this is a pass. As Graham said, price is what you pay, value is what you get; here the value remains unproven.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer